Ignite Creation Date:
2024-05-06 @ 3:55 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02409186
Status:
UNKNOWN
Last Update Posted:
2016-04-21
First Post:
2014-12-03
Brief Title:
A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Shandong Cancer Hospital and Institute
Organization Data
Organization:
Shandong Cancer Hospital and Institute
Class:
OTHER
Study ID:
NXCEL1311
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shandong Cancer Hospital and Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Jinming Yu
Responsible Party Title:
President
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shandong Cancer Hospital and Institute
Old Name:
None
Old Organization:
None